| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
Best S. L., Sadler P. J.; Gold Bulletin, 1996, 29, 87 1;
Bruni B. et al., Croatica Chemica Acta, 1999, 72, 221 1;
Buckley R. G. et al., 1996, 39, 5208 1;
Caruso F. et al., J. Med. Chem., 2003, 46, 1737 1;
Coronello M. et al., Oncol. Res., 2000, 12, 361 1;
EN ISO 10993-15:2000 1;
Elder R. C. et al., J. Am. Chem. Soc., 1985, 107, 5024 1;
Fricker S. P.; Gold Bulletin, 1996, 29, 53 1;
I. Kostova, Anti-Cancer Agents in Medicinal Chemistry, 2006, 6, 19-32 1;
Kostova, Anti-Cancer Agents in Medicinal Chemistry, 2006, 6, 19-32 1;
Mazid M. A. et al., J. Chem. Soc. Chem. Commun., 1980, 1261 1;
McKeage M. J. et al., Cancer Chemother. Pharmacol., 2000, 46, 343 1;
McKeage M. J. et al., J. Coord. Chem. Rev., 2002, 232, 127 1;
Milacic V.; Histol. Histopathol. 2008, 23, 101-108 1;
Parish R. V. Cottrill S. M.; Gold Bulletin 1987, 20, 3 1;
Pillarsetty N. et al., J. Med. Chem., 2003, 46, 1130 1;
Tiekink E. R. T.; Gold Bulletin 2003, 36, 117 1
|
